MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share (MLTX)

CUSIP: 61559X104

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Class A ordinary share, par value $0.0001 per share
Shares outstanding
71,400,541
Total 13F shares
56,057,516
Share change
+16,638,367
Total reported value
$2,858,934,462
Price per share
$51.00
Number of holders
82
Value change
+$861,230,424
Number of buys
71
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 61559X104?
CUSIP 61559X104 identifies MLTX - MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share (MLTX) as of Q2 2023

As of 30 Jun 2023, MoonLake Immunotherapeutics - Class A ordinary share, par value $0.0001 per share (MLTX) was held by 82 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 56,057,516 shares. The largest 10 holders included BVF INC/IL, Cormorant Asset Management, LP, FMR LLC, CITADEL ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, Avoro Capital Advisors LLC, Polar Capital Holdings Plc, ADAGE CAPITAL PARTNERS GP, L.L.C., FEDERATED HERMES, INC., and T. Rowe Price Investment Management, Inc.. This page lists 82 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.